Geneos Wealth Management’s Capital Group Dividend Growers ETF CGDG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
53,752
+4,287
+9% +$160K 0.04% 377
2026
Q1
$1.78M Buy
49,465
+2,378
+5% +$87.1K 0.04% 378
2025
Q4
$1.68M Buy
47,087
+32,355
+220% +$1.14M 0.04% 386
2025
Q3
$510K Sell
14,732
-16,718
-53% -$569K 0.01% 644
2025
Q2
$1.06M Buy
31,450
+15,597
+98% +$496K 0.03% 520
2025
Q1
$490K Buy
+15,853
New +$488K 0.02% 626

Other funds holding CGDG

Geneos Wealth Management's CGDG Position: Q2 2026 in Review

Geneos Wealth Management increased its Capital Group Dividend Growers ETF (CGDG) stake by 8.7% in Q2 2026, buying an estimated $160K and bringing the position to 53,752 shares worth $2.02M. The position accounts for 0.04% of the portfolio, ranked #377.

Geneos Wealth Management first reported a position in CGDG in Q1 2025 and has held it in 6 quarters since. 280 funds tracked by Wall St. Rank hold CGDG as of Q2 2026.

  • Geneos Wealth Management held 53,752 shares of Capital Group Dividend Growers ETF worth $2.02M as of Q2 2026.
  • Geneos Wealth Management bought 4,287 Capital Group Dividend Growers ETF shares in Q2 2026, an estimated $160K.
  • Capital Group Dividend Growers ETF made up 0.04% of Geneos Wealth Management's portfolio in Q2 2026, its #377 holding.
  • Geneos Wealth Management first reported a position in Capital Group Dividend Growers ETF in Q1 2025 and has held it in 6 quarters since.
  • 280 funds tracked by Wall St. Rank held Capital Group Dividend Growers ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.